Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Zura Bio ( (ZURA) ) is now available.
Zura Bio Limited, a clinical-stage immunology company, is set to present at the Piper Sandler 36th Annual Healthcare Conference, showcasing their innovative dual-pathway antibodies for autoimmune and inflammatory diseases. The company is focusing on developing therapeutic indications for three assets, aiming to prove their efficacy and safety in diseases like systemic sclerosis. Investors can catch a live webcast of the event, with a replay available on their website.
See more data about ZURA stock on TipRanks’ Stock Analysis page.
